Impact of anesthesia on cancer recurrence

Revista Espanola de Anestesiologia y Reanimacion

Volumn 62, Issue 10, 2015, Pages 570-575

  Lee, B M ^a   Cata, J P ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Anesthesia and Surgical Oncological Research Group   (United States)

Author keywords

Anesthesia; Angiogenesis; Inflammation; Neoplasms; Recurrence

Indexed keywords

ANESTHETIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE EFFECTS; ANESTHESIA; CLASSIFICATION; DRUG EFFECTS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; METASTASIS; MINIMAL RESIDUAL DISEASE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES; REGIONAL ANESTHESIA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANALGESICS, OPIOID; ANESTHESIA; ANESTHESIA, CONDUCTION; ANESTHETICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME;

EID: 84960467307     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2015.04.003     Document Type: Article

References (52)

1. Society AC: Cancer Facts & Figures 2014. Atlanta; 2014.
2. Markovic S.N., Murasko D.M. Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells. Cell Immunol 1993, 151:474-480.
3. Schilling T., Kozian A., Senturk M., Huth C., Reinhold A., Hedenstierna G., et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology 2011, 115:65-74.
4. Benzonana L.L., Perry N.J., Watts H.R., Yang B., Perry I.A., Coombes C., et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology 2013, 119:593-605.
5. Kawaraguchi Y., Horikawa Y.T., Murphy A.N., Murray F., Miyanohara A., Ali S.S., et al. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology 2011, 115:499-508.
6. Jun R., Gui-he Z., Xing-xing S., Hui Z., Li-xian X. Isoflurane enhances malignancy of head and neck squamous cell carcinoma cell lines: a preliminary study in vitro. Oral Oncol 2011, 47:329-333.
7. Huitink J.M., Heimerikxs M., Nieuwland M., Loer S.A., Brugman W., Velds A., et al. Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesth Analg 2010, 111:1411-1415.
8. Müller-Edenborn B., Roth-Z'graggen B., Bartnicka K., Borgeat A., Hoos A., Borsig L., et al. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology 2012, 117:293-301.
9. Kvolik S., Glavas-Obrovac L., Bares V., Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005, 77:2369-2383.
10. Elias K.M., Kang S., Liu X., Horowitz N.S., Berkowitz R.S., Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol 2015, 22:1341-1348.
11. Salo M., Pirttikangas C.O., Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 1997, 52:341-344.
12. Inada T., Yamanouchi Y., Jomura S., Sakamoto S., Takahashi M., Kambara T., et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia 2004, 59:954-959.
13. Ren X.F., Li W.Z., Meng F.Y., Lin C.F. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia 2010, 65:478-482.
14. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003, 97:1331-1339.
15. Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol 2007, 29(3-4):477-486.
16. Xu Y.B., Du Q.H., Zhang M.Y., Yun P., He C.Y. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci 2013, 17:2486-2494.
17. De Kock M., Loix S., Lavand'homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther 2013, 19:403-410.
18. Tanabe K., Dohi S., Matsuno H., Hirade K., Kozawa O. Midazolam stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of the mitogen-activated protein kinase superfamily. Anesthesiology 2003, 98:1147-1154.
19. Xiang H., Hu B., Li Z., Li J. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation 2014, 37:1763-1770.
20. Chen C., Zhang Z., Chen K., Zhang F., Peng M., Wang Y. Dexmedetomidine regulates inflammatory molecules contributing to ventilator-induced lung injury in dogs. J Surg Res 2014, 187:211-218.
21. Inada T., Kubo K., Kambara T., Shingu K. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can J Anaesth 2009, 56:222-229.
22. Siddiqui R.A., Zerouga M., Wu M., Castillo A., Harvey K., Zaloga G.P., et al. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res 2005, 7:R645-R654.
23. Du Q.H., Xu Y.B., Zhang M.Y., Yun P., He C.Y. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity. World J Gastroenterol 2013, 19:5485-5492.
24. Wang P., Chen J., Mu L.H., Du Q.H., Niu X.H., Zhang M.Y. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug. Eur Rev Med Pharmacol Sci 2013, 17:1722-1729.
25. Szpunar M.J., Burke K.A., Dawes R.P., Brown E.B., Madden K.S. The antidepressant desipramine and alpha2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure. Cancer Prev Res (Phila) 2013, 6:1262-1272.
26. Bruzzone A., Pinero C.P., Castillo L.F., Sarappa M.G., Rojas P., Lanari C., et al. Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 2008, 155:494-504.
27. Berger C., Rossaint J., Van Aken H., Westphal M., Hahnenkamp K., Zarbock A. Lidocaine reduces neutrophil recruitment by abolishing chemokine-induced arrest and transendothelial migration in septic patients. J Immunol 2014, 192:367-376.
28. Yardeni I.Z., Beilin B., Mayburd E., Levinson Y., Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 2009, 109:1464-1469.
29. Lahat A., Ben-Horin S., Lang A., Fudim E., Picard O., Chowers Y. Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol 2008, 152:320-327.
30. Ramirez M.F., Tran P., Cata J.P. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med 2015, 40:43-48.
31. Jejurikar S.S., Welling T.H., Zelenock J.A., Gordon D., Burkel W.E., Carlson B.M., et al. Induction of angiogenesis by lidocaine and basic fibroblast growth factor: a model for in vivo retroviral-mediated gene therapy. J Surg Res 1997, 67:137-146.
32. Sakaguchi M., Kuroda Y., Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006, 102:1103-1107.
33. Werdehausen R., Fazeli S., Braun S., Hermanns H., Essmann F., Hollmann M.W., et al. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth 2009, 103:711-718.
34. Yardeni I.Z., Beilin B., Mayburd E., Alcalay Y., Bessler H. Relationship between fentanyl dosage and immune function in the postoperative period. J Opioid Manag 2008, 4:27-33.
35. Godai K., Hasegawa-Moriyama M., Kurimoto T., Saito T., Yamada T., Sato T., et al. Peripheral administration of morphine attenuates postincisional pain by regulating macrophage polarization through COX-2-dependent pathway. Mol Pain 2014, 10:36.
36. Lennon F.E., Mirzapoiazova T., Mambetsariev B., Salgia R., Moss J., Singleton P.A. Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 2012, 116:857-867.
37. Lennon F.E., Mirzapoiazova T., Mambetsariev B., Poroyko V.A., Salgia R., Moss J., et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLOS ONE 2014, 9:e91577.
38. Cata J.P., Keerty V., Keerty D., Feng L., Norman P.H., Gottumukkala V., et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med 2014, 3:900-908.
39. Sasamura T., Nakamura S., Iida Y., Fujii H., Murata J., Saiki I., et al. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 2002, 441:185-191.
40. Shakhar G., Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 2003, 10:972-992.
41. Singh B., Cook K.R., Vincent L., Hall C.S., Martin C., Lucci A. Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res 2011, 168:e39-e49.
42. Martinet L., Jean C., Dietrich G., Fournié J.J., Poupot R. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochem Pharmacol 2010, 80:838-845.
43. Chattopadhyay S., Bhattacharyya S., Saha B., Chakraborty J., Mohanty S., Sakib Hossain D.M., et al. Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4T cell survival: regulation by theaflavins. PLoS ONE 2009, 4:e7382.
44. Ahmadi M., Emery D.C., Morgan D.J. Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res 2008, 68:7520-7529.
45. Barlow M., Edelman M., Glick R.D., Steinberg B.M., Soffer S.Z. Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. J Pediatr Surg 2012, 47:1223-1227.
46. Forget P., Machiels J.P., Coulie P.G., Berliere M., Poncelet A.J., Tombal B., et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 2013, 20:S650-S660.
47. Sessler D.I., Ben-Eliyahu S., Mascha E.J., Parat M.O., Buggy D.J. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials 2008, 29:517-526.
48. Wada H., Seki S., Takahashi T., Kawarabayashi N., Higuchi H., Habu Y., et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007, 106:499-506.
49. Bar-Yosef S., Melamed R., Page G.G., Shakhar G., Shakhar K., Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001, 94:1066-1073.
50. Conrick-Martin I., Kell M.R., Buggy D.J. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth 2012, 24:3-7.
51. Buckley A., McQuaid S., Johnson P., Buggy D.J. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Br J Anaesth 2014, 113:i56-i62.
52. Chen W.K., Miao C.H. The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PLOS ONE 2013, 8:e56540.